ESC 2021: Therapeutic Dose of Low Molecular Weight Heparin Outperforms Prophylactic Dose in Patients With Severe COVID-19
Author suggests results of HEP-COVID are robust enough to change practice guidance
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.